Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan
· Delayed Price · Currency is TWD 419.00
+11.00 (2.70%)
May 23, 2025, 1:30 PM CST
Sunmax Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 726.36 | 679.41 | 625.71 | 533.83 | 245.64 | 238.08 | Upgrade
|
| Depreciation & Amortization | 100.59 | 99.21 | 72.83 | 58.15 | 55.76 | 33.8 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.48 | 0.49 | 0.13 | -0.46 | 2.1 | -1.34 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | 8.32 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | -0.39 | 0.24 | -2.38 | Upgrade
|
| Other Operating Activities | -24.94 | -21.59 | 17.96 | 42.52 | 18.34 | -1.97 | Upgrade
|
| Change in Accounts Receivable | -0.93 | 0.47 | -0.23 | 3.34 | 1.81 | 12.81 | Upgrade
|
| Change in Inventory | -34.78 | -63.69 | -19.88 | -19.05 | -29.41 | 6.1 | Upgrade
|
| Change in Accounts Payable | -2.16 | 11.35 | -7.61 | 9.46 | 3.58 | -3.34 | Upgrade
|
| Change in Unearned Revenue | -86.07 | -128.72 | 142.48 | -62.86 | 11.01 | 50.81 | Upgrade
|
| Change in Other Net Operating Assets | -3.37 | -15.91 | 17.17 | 80.03 | -65.8 | 46.09 | Upgrade
|
| Operating Cash Flow | 675.18 | 561.04 | 848.56 | 644.57 | 243.28 | 386.97 | Upgrade
|
| Operating Cash Flow Growth | -12.58% | -33.88% | 31.65% | 164.95% | -37.13% | 33.67% | Upgrade
|
| Capital Expenditures | -25.28 | -31.97 | -107.66 | -154.58 | -253.02 | -129.87 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.42 | 0.51 | 3.1 | 0.61 | Upgrade
|
| Cash Acquisitions | -7.2 | -7.2 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -5.35 | -5.03 | -2.73 | -0.59 | -2.4 | -0.23 | Upgrade
|
| Investment in Securities | 3.01 | 24.96 | 125 | -136.43 | 39.68 | 28.88 | Upgrade
|
| Other Investing Activities | -7.11 | -2.71 | -30.1 | -85.53 | -72.53 | -1.29 | Upgrade
|
| Investing Cash Flow | -41.92 | -21.94 | -16.04 | -376.62 | -285.17 | -101.9 | Upgrade
|
| Long-Term Debt Repaid | - | -29.65 | -22.97 | -39.16 | -24.39 | -14.81 | Upgrade
|
| Net Debt Issued (Repaid) | -29.97 | -29.65 | -22.97 | -39.16 | -24.39 | -14.81 | Upgrade
|
| Common Dividends Paid | -599.09 | -599.09 | -517.4 | -239.64 | -108.93 | -81.7 | Upgrade
|
| Other Financing Activities | 1.37 | 2.64 | -9.43 | -2.41 | 1.35 | 1.13 | Upgrade
|
| Financing Cash Flow | -627.69 | -626.11 | -549.8 | -281.21 | -131.97 | -95.38 | Upgrade
|
| Foreign Exchange Rate Adjustments | 7.03 | 7.79 | -17.33 | 0.01 | -2.18 | 5.39 | Upgrade
|
| Net Cash Flow | 12.6 | -79.23 | 265.39 | -13.25 | -176.03 | 195.09 | Upgrade
|
| Free Cash Flow | 649.91 | 529.07 | 740.9 | 489.99 | -9.74 | 257.11 | Upgrade
|
| Free Cash Flow Growth | -4.84% | -28.59% | 51.21% | - | - | -6.79% | Upgrade
|
| Free Cash Flow Margin | 33.42% | 29.10% | 43.87% | 35.00% | -0.94% | 30.04% | Upgrade
|
| Free Cash Flow Per Share | 11.92 | 9.70 | 13.59 | 8.98 | -0.18 | 4.71 | Upgrade
|
| Cash Interest Paid | 5.95 | 5.95 | 2.94 | 1.35 | 2.81 | 2.92 | Upgrade
|
| Cash Income Tax Paid | 289.64 | 289.64 | 259.68 | 199.74 | 92.59 | 100.69 | Upgrade
|
| Levered Free Cash Flow | 1,109 | 400.4 | 612.07 | 412.52 | 7.73 | 152.81 | Upgrade
|
| Unlevered Free Cash Flow | 1,112 | 404.12 | 613.91 | 413.36 | 9.48 | 154.63 | Upgrade
|
| Change in Net Working Capital | -421.96 | 237.46 | -92.23 | -30.39 | 20.46 | -43.23 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.